North Peak Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIGR
Figure Technology Solutions
FIGR
|
+$77.1M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$40.6M |
| 3 |
Celsius Holdings
CELH
|
+$37.7M |
| 4 |
Carvana
CVNA
|
+$14.3M |
| 5 |
Sea Limited
SE
|
+$12.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Driven Brands
DRVN
|
+$63.7M |
| 2 |
Haemonetics
HAE
|
+$42.1M |
| 3 |
Agilon Health
AGL
|
+$3.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 50.82% |
| 2 | Financials | 24.75% |
| 3 | Healthcare | 20.54% |
| 4 | Consumer Staples | 3.89% |
Similar funds
North Peak Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, North Peak Capital Management held 9 positions worth $900M, up 50% from $601M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
North Peak Capital Management deployed $73.6M of net new capital in Q2 2026, opening 2 new positions and adding to 4 existing holdings. Its largest new stake was Figure Technology Solutions: 2,307,148 shares worth $70.9M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 51% of assets, down from 70% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Haemonetics, an estimated $42.1M trimmed.
- North Peak Capital Management's largest Q2 2026 buy was Figure Technology Solutions: 2,307,148 shares worth $70.9M.
- North Peak Capital Management added most to Charles Schwab in Q2 2026, an estimated $40.6M increase.
- North Peak Capital Management's biggest Q2 2026 reduction was Haemonetics, cutting an estimated $42.1M.
- North Peak Capital Management fully exited Driven Brands in Q2 2026, selling an estimated $63.7M.
- North Peak Capital Management's ten largest holdings make up 100% of its $900M portfolio in Q2 2026.
- North Peak Capital Management opened 2 new positions and closed 1 in Q2 2026.
- North Peak Capital Management's portfolio value rose 50% quarter-over-quarter to $900M.
Based on North Peak Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.